title: Good pharma? Bad pharma? Better pharma.
authors.affiliation: M Hardman, AstraZeneca PLC Innovative Medicines and Early Development, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. Email mike.hardman@astrazeneca.com.
authors.forename: M
authors.initials: M
authors.lastname: Hardman
mesh_terms: D002986:Clinical Trials as Topic / Q000191:economics / Q000331:legislation & jurisprudence / Q000592:standards*; D016265:Conflict of Interest / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence / Q000592:standards*; D005062:European Union; D033161:Government Regulation; D033181:Information Dissemination; D012109:Research Support as Topic / Q000331:legislation & jurisprudence; D006113:United Kingdom
keywords: clinical trial data; collaboration; payments; pharmaceutical industry